Unintended lower-segment hysterotomy extension at cesarean delivery and the risk for uterine rupture during a subsequent trial of labor.


Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174

Informations de publication

Date de publication:
Sep 2023
Historique:
revised: 12 03 2023
received: 29 11 2022
accepted: 28 03 2023
medline: 15 8 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

To evaluate the association between unintended uterine extension in cesarean delivery and uterine scar disruption (rupture or dehiscence) at the subsequent trial of labor after cesarean delivery (TOLAC). This is a multicenter retrospective cohort study (2005-2021). Parturients with a singleton pregnancy who had unintended lower-segment uterine extension during the primary cesarean delivery (excluding T and J vertical extensions) were compared with patients who did not have an unintended uterine extension. We assessed the subsequent uterine scar disruption rate following the subsequent TOLAC and the rate of adverse maternal outcome. During the study period, 7199 patients underwent a trial of labor and were eligible for the study, of whom 1245 (17.3%) had a previous unintended uterine extension and 5954 (82.7%) did not. In univariate analysis, previous unintended uterine extension during the primary cesarean delivery was not significantly associated with uterine scar rupture in the following subsequent TOLAC. Nevertheless, it was associated with uterine scar dehiscence, higher rates of TOLAC failure, and a composite adverse maternal outcome. In multivariate analyses, only the association between previous unintended uterine extension and higher rates of TOLAC failure was confirmed. A history of unintended lower-segment uterine extension is not associated with an increased risk for uterine scar disruption following subsequent TOLAC.

Identifiants

pubmed: 37074521
doi: 10.1002/ijgo.14785
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

957-963

Informations de copyright

© 2023 International Federation of Gynecology and Obstetrics.

Références

Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67(8):1-50.
Shanks AL, Cahill AG. Delivery after prior cesarean: success rate and factors. Clin Perinatol. 2011;38(2):233-245.
Royal College of Obstetricians & Gynaecologists. Birth after previous caesarean birth (Green-top Guideline No. 45). 2007.
ACOG. ACOG practice bulletin no. 115: vaginal birth after previous cesarean delivery. Obstet Gynecol. 2010;116(2 Pt 1):450.
Machado Junior LC, Famá EAB, Zamboni JW, et al. Risk score for failed trial of vaginal birth after a previous cesarean section including data of labor course. J Obstet Gynaecol Res. 2020;46(1):93-103.
El-Sayed YY, Watkins MM, Fix M, Druzin ML, Pullen KM, Caughey AB. Perinatal outcomes after successful and failed trials of labor after cesarean delivery. Am J Obstet Gynecol. 2007;196(6):583.e1-583.e5. discussion 583.e5.
Ashwal E, Lavie A, Blecher Y, et al. Intrapartum cesarean delivery and the risk of perinatal complications in women with and without a single prior cesarean delivery. Int J Gynaecol Obstet. 2022;157(2):359-365.
Karavani G, Chill HH, Reuveni-Salzman A, et al. Risk factors for uterine incision extension during cesarean delivery. J Matern Fetal Neonatal Med. 2022;35(11):2156-2161.
Lurie S, Raz N, Boaz M, Sadan O, Golan A. Comparison of maternal outcomes from primary cesarean section during the second compared with first stage of labor by indication for the operation. Eur J Obstet Gynecol Reprod Biol. 2014;182:43-47.
Patel SS, Koelper NC, Srinivas SK, Sammel MD, Levine LD. Adverse maternal outcomes associated with uterine extensions at the time of cesarean delivery. Am J Perinatol. 2019;36(8):785-789.
de la Torre L, González-Quintero VH, Mayor-Lynn K, et al. Significance of accidental extensions in the lower uterine segment during cesarean delivery. Am J Obstet Gynecol. 2006;194(5):e4-e6.
Cromi A, Ghezzi F, Di Naro E, Siesto G, Loverro G, Bolis P. Blunt expansion of the low transverse uterine incision at cesarean delivery: a randomized comparison of 2 techniques. Am J Obstet Gynecol. 2008;199(3):292.e1-292.e6.
Bligard KH, Durst JK, Stout MJ, et al. Risk factors and maternal morbidity associated with unintentional Hysterotomy extension at the time of cesarean delivery. Am J Perinatol. 2019;36(10):1054-1059.
Isquick S, Henry D, Nakagawa S, et al. The association between nitroglycerin use and adverse outcomes in women undergoing cesarean delivery in the second stage of labor. J Matern Fetal Neonatal Med. 2017;30(11):1297-1301.
Giugale LE, Sakamoto S, Yabes J, Dunn SL, Krans EE. Unintended hysterotomy extension during caesarean delivery: risk factors and maternal morbidity. J Obstet Gynaecol. 2018;38(8):1048-1053.
Wilkie G, Shipp TD, Little SE, Fadayomi A, Carusi DA. Hysterotomy extension at cesarean delivery and future uterine rupture. Obstet Gynecol. 2021;137(2):271-272.
Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med. 2004;351(25):2581-2589.
Smith JG, Mertz HL, Merrill DC. Identifying risk factors for uterine rupture. Clin Perinatol. 2008;35(1):85-99. viii.
Tan SQ, Chen LH, Muhd Abdul Qadir DB, Chern BSM, Yeo GSH. Risk factors and outcomes of uterine rupture in Singapore: emerging trends. Ann Acad Med Singap. 2021;50(1):5-15.
Figueiró-Filho EA, Gomez JM, Farine D. Risk factors associated with uterine rupture and dehiscence: a cross-sectional Canadian study. Rev Bras Ginecol Obstet. 2021;43(11):820-825.

Auteurs

Tzuria Peled (T)

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.

Eran Ashwal (E)

Department of Obstetrics and Gynecology, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.

Reut Rotem (R)

Department of Obstetrics and Gynecology, McMaster University Medical Center, McMaster University, Hamilton, Ontario, Canada.

Hen Y Sela (HY)

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.

Sorina Grisaru-Granovsky (S)

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.

Misgav Rottenstreich (M)

Department of Obstetrics and Gynecology, Shaare Zedek Medical Center affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.
Department of Nursing, Jerusalem College of Technology, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH